Gevo (NASDAQ:GEVO) Stock Rating Lowered by Zacks Investment Research

Gevo (NASDAQ:GEVO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

Other equities research analysts have also issued research reports about the stock. HC Wainwright reiterated a “buy” rating and set a $10.00 price objective on shares of Gevo in a research note on Thursday, August 15th. ValuEngine lowered shares of Gevo from a “buy” rating to a “hold” rating in a research note on Friday, August 16th.

GEVO opened at $2.79 on Wednesday. The firm has a market cap of $35.84 million, a price-to-earnings ratio of -0.53 and a beta of 2.70. Gevo has a fifty-two week low of $1.79 and a fifty-two week high of $4.97. The company’s 50-day moving average price is $2.45 and its 200 day moving average price is $2.26.

In other Gevo news, insider Timothy J. Cesarek acquired 25,000 shares of the company’s stock in a transaction that occurred on Thursday, June 6th. The shares were purchased at an average price of $1.91 per share, for a total transaction of $47,750.00. Following the completion of the purchase, the insider now directly owns 30,000 shares in the company, valued at $57,300. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.41% of the stock is owned by corporate insiders.

An institutional investor recently bought a new position in Gevo stock. Wedbush Securities Inc. purchased a new stake in Gevo Inc (NASDAQ:GEVO) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 30,500 shares of the energy company’s stock, valued at approximately $67,000. Wedbush Securities Inc. owned approximately 0.26% of Gevo at the end of the most recent reporting period. 6.91% of the stock is owned by institutional investors and hedge funds.

Gevo Company Profile

Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.

Recommended Story: Front-End Load

Get a free copy of the Zacks research report on Gevo (GEVO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.